We are live on ! Find out more
ALDX icon

Aldeyra Therapeutics
ALDX

120 hedge funds and large institutions have $252M invested in Aldeyra Therapeutics in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 41 increasing their positions, 37 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 37

7% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 14

1% more funds holding

Funds holding: 119 → 120 (+1)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

2.18% less ownership

Funds ownership: 66.64% → 64.46% (-2.2%)

23% less capital invested

Capital invested by funds: $328M → $252M (-$75.2M)

38% less call options, than puts

Call options by funds: $1.34M | Put options by funds: $2.16M

Holders
120
Holders Change
+1
Holders Change %
+0.84%
% of All Funds
1.9%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
41
Reduced
37
Closed
14
Calls
$1.34M
Puts
$2.16M
Net Calls
-$820K
Net Calls Change
+$2.53M

Top Buyers

1
BlackRock
BlackRock
New York
+$1.04M
2
Two Sigma Investments
Two Sigma Investments
New York
+$1.01M
3
Citadel Advisors
Citadel Advisors
Florida
+$999K
4
LCM
Laurion Capital Management
New York
+$946K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$740K

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.02M
2
Invesco
Invesco
Georgia
-$3.47M
3
Marshall Wace
Marshall Wace
United Kingdom
-$1.54M
4
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$1.42M
5
AllianceBernstein
AllianceBernstein
Tennessee
-$1.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
CCIA
101
Campbell & Co Investment Adviser
Maryland
$70.6K -$5.33K -718 -6%
PI
102
PFG Investments
New York
$70.1K – – –
GCM
103
Graham Capital Management
Connecticut
$67.6K +$75.1K +10,123 New
CIBC World Market
104
CIBC World Market
Ontario, Canada
$67K – – –
SM
105
Scoggin Management
New York
$66.8K +$74.2K +10,000 New
VEA
106
Virtus ETF Advisers
New York
$63.2K -$6.98K -941 -9%
AB
107
Amalgamated Bank
New York
$47K – – –
Royal Bank of Canada
108
Royal Bank of Canada
Ontario, Canada
$39K +$21.8K +2,940 +101%
Fidelity Investments
109
Fidelity Investments
Massachusetts
$33.1K -$5.02M -676,304 -99%
FDCDDQ
110
Federation des caisses Desjardins du Quebec
Quebec, Canada
$30.4K -$48.1K -6,485 -59%
AIP
111
Ameritas Investment Partners
Nebraska
$25.7K – – –
MLICM
112
Metropolitan Life Insurance Company (MetLife)
New York
$17.1K – – –
TRCT
113
Tower Research Capital (TRC)
New York
$12.7K -$17.9K -2,414 -56%
SC
114
Stephens Consulting
Michigan
$6.68K – – –
LC
115
Lindbrook Capital
California
$5.2K – – –
PA
116
PSI Advisors
Florida
$3.34K – – –
TC
117
Truvestments Capital
Florida
$1.77K – – –
HWM
118
HighMark Wealth Management
Minnesota
$1.03K – – –
Comerica Bank
119
Comerica Bank
Texas
$501 +$556 +75 New
IFAM
120
Institutional & Family Asset Management
Colorado
$341 – – –
Marshall Wace
121
Marshall Wace
United Kingdom
– -$1.54M -183,337 Closed
Connor, Clark & Lunn Investment Management (CC&L)
122
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$1.42M -169,306 Closed
PM
123
Prosight Management
Texas
– -$1.25M -149,511 Closed
JMPWA
124
JP Morgan Private Wealth Advisors
California
– -$840K -100,111 Closed
TLP
125
Tri Locum Partners
New York
– -$613K -73,067 Closed
2 3 4
5
6

ALDX Hedge Fund Activity: Q3 2023 in Review

120 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Aldeyra Therapeutics (ALDX) for Q3 2023, worth a combined $252M — down 23% from $328M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new ALDX positions and 14 closed out — a net gain of 1 holder — while 41 added to existing stakes and 37 trimmed.

The largest buyer was BlackRock, adding an estimated $1.04M. The largest seller was Fidelity Investments, cutting an estimated $5.02M.

  • 120 institutional investors held Aldeyra Therapeutics (ALDX) as of Q3 2023, up from 119 in Q2 2023.
  • Funds reported $252M of Aldeyra Therapeutics stock for Q3 2023, down 23% quarter-over-quarter.
  • 15 funds opened new Aldeyra Therapeutics positions in Q3 2023 and 14 closed out, a net change of +1 holder.
  • The largest Aldeyra Therapeutics buyer in Q3 2023 was BlackRock, an estimated $1.04M added.
  • The largest Aldeyra Therapeutics seller in Q3 2023 was Fidelity Investments, an estimated $5.02M sold.

Based on aggregated 13F filings for Q3 2023.